NCT02708004View on ClinicalTrials.gov

Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 1, 2016

Study Completion Date

December 1, 2016

Conditions
Healthy Subjects
Interventions
DRUG

Aprocitentan

Formulated in capsules in 2 different strengths; 2 capsules per day

OTHER

Placebo

Matching active drug

Trial Locations (1)

1011

Investigator Site Lausanne, Lausanne

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY